Methode Electronics, Inc. Reports Fiscal 2026 Second Quarter Financial Results
Globenewswire· 2025-12-03 21:11
Net sales of $246.9 million down 15.6% year-over-year; up 2.6% on a sequential quarter basisNet loss of $9.9 million or 4.0% of net sales; adjusted EBITDA margin of 7.1%Reaffirming fiscal 2026 guidance for net sales of $900 million to $1 billion and adjusted EBITDA of $70 to $80 million CHICAGO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting, and power distribution applications, today announced fi ...
Picard Medical, Inc. and SynCardia Systems LLC CEO to Present at CSI Focus D-HF 2025 in Frankfurt, Germany
Globenewswire· 2025-12-03 21:05
TUCSON, Ariz., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that Patrick NJ Schnegelsberg, CEO will attend and present data on the fully implantable Emperor Total Artificial Heart (TAH) at the upcoming CSI Focus D-HF (Device Therapies in Heart Failure) conference, scheduled for December 5th thro ...
Coherent Expands Silicon Carbide Platform with 300mm Capability to Support Growing Demand of AI and Datacenters
Globenewswire· 2025-12-03 21:05
SAXONBURG, Pa., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced a major milestone in its next-generation 300mm silicon carbide (SiC) platform to address increasing thermal efficiency demands in AI datacenter infrastructure. Coherent, a pioneer in large-diameter SiC substrates, has leveraged its proven 200mm platform expertise to develop a next-generation 300mm solution, engineered to manage rising thermal loads, that meets the accelerating perform ...
Nasdaq to Present at Upcoming Investor Conference
Globenewswire· 2025-12-03 21:05
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference with webcast available at Nasdaq’s Investor Relations website: ir.nasdaq.com/events.cfm. Who:Sarah Youngwood, Executive Vice President and CFO, NasdaqWhat:Goldman Sachs 2025 Financial Services ConferenceWhen:Wednesday, December 10, 20251:00 PM ET About NasdaqNasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange ...
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update
Globenewswire· 2025-12-03 21:05
– Fourth quarter fiscal 2025 revenue up 5.9% to $138.1 million– Fiscal 2025 revenue increased 4.5% to $513.0 million– Fourth quarter fiscal 2025 operating loss decreased 48.5% to $6.8 million– Fiscal 2025 operating loss decreased 64.2% to $30.9 million– Conference call scheduled for today at 4:30 pm ET WEST LAFAYETTE, Ind., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and deve ...
Soleno Therapeutics Announces the Passing of Board Member William G. Harris
Globenewswire· 2025-12-03 21:05
REDWOOD CITY, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today regrets to announce the passing of William G. “Bill” Harris, who served as a valued member of Soleno’s Board of Directors since June 2014. Mr. Harris also served as Chairman of the Audit Committee. “I have known Bill for many years, and always viewed him as a person of integrity, who exhibited pragmatism ...
TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities
Globenewswire· 2025-12-03 21:05
WALTHAM, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced the Company will host a virtual key opinion leader (KOL) event to discuss updated data from the ALLOHA™ Phase 1 trial being presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition and the future market ...
Digital Realty Announces Redemption of 2.500% Guaranteed Notes due 2026
Globenewswire· 2025-12-03 21:05
AUSTIN, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the largest global provider of cloud- and carrier-neutral data center, colocation and interconnection solutions, announced today that Digital Euro Finco, LLC, a wholly owned indirect finance subsidiary of Digital Realty’s operating partnership, has given notice of its intention to redeem all of its outstanding 2.500% Guaranteed Notes due 2026, pursuant to its option under the indenture governing the 2.500% notes, dated as of Januar ...
nCino Reports Third Quarter Fiscal Year 2026 Financial Results
Globenewswire· 2025-12-03 21:05
Total Revenues of $152.2M, up 10% year-over-year Subscription Revenues of $133.4M, up 11% year-over-yearGAAP Operating Margin of 8%, up over 800 basis points year-over-yearNon-GAAP Operating Margin of 26%, up 600 basis points year-over-year WILMINGTON, N.C., Dec. 03, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced financial results for the third quarter of fiscal year 2026, ended October 31, 2025. "I'm extremely proud ...
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
Globenewswire· 2025-12-03 21:05
ROCKVILLE, Md., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack A. Khattar, President and CEO of Supernus Pharmaceuticals, will present at the Bank of America Securities 2025 CNS Therapeutics Virtual Conference on Monday, December 8, 2025, at 3:20 p.m. ET. Investors interested in arranging a meeting with company ...